Alkem launches generic empagliflozin low-cost diabetes drug in India

Table of Content


Mumbai-based Alkem Laboratories announced today the launch of generic empagliflozin and its combinations in India under the brand name “Empanorm.” The medication, which treats type-2 diabetes, chronic kidney disease, and heart failure, will be priced approximately 80 per cent lower than innovator products.

The shares of Alkem Laboratories Limited were trading today at ₹4,709 down by ₹68.75 or 1.44 per cent on the NSE today at 12.18 pm.

The company is introducing several combination therapies including Empanorm L (empagliflozin and linagliptin), Empanorm Duo and Alsita E (empagliflozin and sitagliptin), and Empanorm M (empagliflozin and metformin).

Alkem’s versions feature an anti-counterfeit security band and include comprehensive patient education materials in multiple languages. The company has also developed a smaller tablet size for patient convenience.

“As we expand and strengthen our chronic portfolio, the introduction of generic empagliflozin in India is an important milestone,” said Dr. Vikas Gupta, Alkem’s CEO. He added that the company plans to leverage its distribution network to improve treatment accessibility nationwide.

Empagliflozin is an SGLT-2 inhibitor that has shown benefits beyond diabetes management, including positive effects on cardiovascular and kidney health.

The fifth-largest pharmaceutical company in India, Alkem operates 19 manufacturing facilities and various R&D centers across India and the US. The company specializes in anti-infectives, gastrointestinal medications, pain management drugs, and supplements, while expanding its chronic therapy offerings.





Source link

AIMPWA

mmkrishnandasu@gmail.com http://msmenews.sbs

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent News

Trending News

Editor's Picks

Budget sows seeds of change for agriculture but gaps remain

The Economic Survey called agriculture the “sector of the future” and the FM echoed this sentiment in her budget speech, emphasizing garib, youth, annadata and nari. Despite this focus, key gaps remain. Firstly, there is a budget cut for agriculture ministry. Despite the rhetoric, the Ministry of Agriculture and Farmers’ Welfare (MOA) saw a ₹3,500...

Incentives for urban governance to improve quality of life

Finance minister Nirmala Sitharaman has followed a stable trajectory in all her Union Budgets since 2019. This year’s budget speech, though, was unusual in not mentioning allocations for specific Infrastructure sectors. The unsaid implication being – execute and implement existing projects in large sectors like highways and railways. Of the allocation to Infrastructure of an...

ALL INDIA MSMES PROMOTION AND WELFARE ASSOCIATION

Quick Links

Popular Categories

Must Read

AIMPWA © 2025- All Right Reserved. Designed and Developed by  growGX.com